Virus-based Tools: Lentivirus, AAV und VSV

Virus-based tools can be used to manipulate genetic material and study viral infections. Our partner BPS Bioscience offers infection systems based on lentiviruses, adeno-associated viruses (AAV) or the vesicular stomatitis virus (VSV). Lentiviruses can be used to generate stably transfected cell lines, they have a high infection rate (>90%), provide high levels of subsequent protein expression, and can be used both in vitro and in vivo. Learn more about lentiviruses and potential applications in our blog. AAVs are useful as viral vectors because they can carry a gene of interest up to 5 kb in length. Because they lead to stable gene expression and they can be used safely due to their low immunogenicity, AAVs are the vectors of choice for the development of many gene therapies. The enveloped VSV provides a valuable tool for studying viral entry, replication, and assembly. VSV-G, the glycoprotein of the virus, is responsible for the attachment and entry of VSVs into the host cell and is often used to pseudotype viral vectors.

Virus-based tools can be used to manipulate genetic material and study viral infections. Our partner  BPS Bioscience offers infection systems based on lentiviruses, adeno-associated... read more »
Close window
Virus-based Tools: Lentivirus, AAV und VSV

Virus-based tools can be used to manipulate genetic material and study viral infections. Our partner BPS Bioscience offers infection systems based on lentiviruses, adeno-associated viruses (AAV) or the vesicular stomatitis virus (VSV). Lentiviruses can be used to generate stably transfected cell lines, they have a high infection rate (>90%), provide high levels of subsequent protein expression, and can be used both in vitro and in vivo. Learn more about lentiviruses and potential applications in our blog. AAVs are useful as viral vectors because they can carry a gene of interest up to 5 kb in length. Because they lead to stable gene expression and they can be used safely due to their low immunogenicity, AAVs are the vectors of choice for the development of many gene therapies. The enveloped VSV provides a valuable tool for studying viral entry, replication, and assembly. VSV-G, the glycoprotein of the virus, is responsible for the attachment and entry of VSVs into the host cell and is often used to pseudotype viral vectors.

22 from 29 pages
No results were found for the filter!
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G...

Item number: BPS-78642-1

The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1, with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene, therefore, the spike-mediated cell entry can be...
Application: Neutralizing antibody screening/titration, virus entry modelling in Vero-E6 / ACE2-HEK293 cells
From 1,189.00€ *
Review
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78651-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Application: Neutralizing antibody screening / titration in ACE2-HEK293 cells
From 1,307.00€ *
Review
MART-1-Specific TCR Lentivirus (Clone DMF4)
MART-1-Specific TCR Lentivirus (Clone DMF4)

Item number: BPS-78678-1

The human MART-1-specific T Cell Receptor lentiviruses (clone DMF4) are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce a human TCR (clone DMF4) that specifically...
Keywords: MART1, MLANA, MART-1, Antigen LB39-AA, Protein Melan-A, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1,
Application: Positive control, experim. condition optimization, stable cell line (puromycin resistant) generation
Species reactivity: human
From 1,795.00€ *
Review
Spike (XBB.1.5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Spike (XBB.1.5, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78737-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Neutralizing antibody screening in ACE2-HEK293 cells
Species reactivity: SARS-CoV-2
From 1,307.00€ *
Review
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78652-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Application: Neutralizing antibody screening in ACE2-HEK293 cells
From 1,285.00€ *
Review
Spike (BQ.1.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Spike (BQ.1.1, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78701-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Neutralizing antibody screening in ACE2-HEK293 cells
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
Spike (BA.2, Omicron Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)
Spike (BA.2, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78635-1

The Spike (BA.2 Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the Omicron BA.2 mutations, see below for details) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene,...
Application: Neutralizing antibody screening/titration, virus entry modelling in Vero-E6, Calu-3, ACE2-HEK293 cells
From 1,189.00€ *
Review
Bald VSV Delta G (Luciferase Reporter)
Bald VSV Delta G (Luciferase Reporter)

Item number: BPS-78636-1

The bald VSV Delta G (Luciferase Reporter) was produced without envelope glycoproteins. It contains the firefly luciferase gene as the reporter. The bald VSV Delta G (Luciferase Reporter) can serve as a negative control when studying virus entry initiated by specific interactions between virus particles and receptors.
Keywords: G, Glycoprotein,
Application: Negative control, VSV delta G pseudotype transduction studies
From 596.00€ *
Review
Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)
Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2)...

Item number: BPS-78643-1

The Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the Omicron BA.2.12.1 mutations, see below for details) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the...
Application: Neutralizing antibody screening/titration, virus entry modelling in Vero-E6, Calu-3, ACE2-HEK293 cells
From 1,189.00€ *
Review
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78644-1

The Spike protein of BA.4 and BA.5 variants of SARS-CoV-2 have identical mutations. In this datasheet, the spike protein of BA.4 and BA.5 are referred to as BA.4/5. The Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession...
Application: Neutralizing antibody screening/titration, virus entry modelling in Vero-E6, Calu-3, ACE2-HEK293 cells
From 1,189.00€ *
Review
NY-ESO-1-Specific TCR Lentivirus (Clone c259)
NY-ESO-1-Specific TCR Lentivirus (Clone c259)

Item number: BPS-78676-1

The human NY-ESO-1-specific T Cell Receptor (TCR) lentiviruses (clone c259, also called alpha95:LY) are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce cells with...
Keywords: CT2, ESO2, CTAG2, CT6.2, LAGE-1, Cancer/testis antigen 2, Cancer/testis antigen 6.2, L antigen family member 1,...
Application: Positive control, experim. condition optimization, stable cell line (puromycin resistant) generation
Species reactivity: human
From 1,795.00€ *
Review
Spike (BQ.1.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luciferase Reporter)
Spike (BQ.1.1, Omicron Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78698-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Neutralizing antibody screening/titration in ACE2-HEK293 cells
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
22 from 29 pages